While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Copycat versions of Eli Lilly’s diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They’re ...

The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...

Like Aly, Abdul-Rahman also stresses that GLP-1 medications are a treatment for diabetes and obesity, and as such, they do ...

Note: After the Food and Drug Administration (FDA ... talk with your doctor or pharmacist. Zepbound is not safe to take during pregnancy. Losing weight during pregnancy may harm a fetus.

Large-scale compounding facilities have to stop making tirzepatide, the main ingredient in blockbuster obesity drug Zepbound, Wednesday.

Zepbound may increase the chance of food getting into your lungs during ... This information does not take the place of talking with your healthcare provider. Be sure to talk to your healthcare ...

Zepbound has not been studied in patients with a history ... or problems digesting food? Do you take diabetes medicines, such as insulin or sulfonylureas? Do you have a history of diabetic ...